I'm LongbridgeAI, I can summarize articles.Bell Potter analyst Martyn Jacobs maintained a Buy rating on Medical Developments International Limited (MVP) with a price target of A$1.00. The stock holds a Moderate Buy consensus among analysts, aligning with the same A$1.00 price target consensus.
Bell Potter analyst Martyn Jacobs maintained a Buy rating on Medical Developments International Limited today and set a price target of A$1.00.
Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Jacobs is an analyst with an average return of -15.3% and a 22.00% success rate. Jacobs covers the Healthcare sector, focusing on stocks such as Lumos Diagnostics Holdings Ltd., Artrya Limited, and Sonic Healthcare Limited.
Medical Developments International Limited has an analyst consensus of Moderate Buy, with a price target consensus of A$1.00.